 | • レポートコード：QYR2104Z1305 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、軟骨肉腫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（外科的治療、化学療法、放射線療法）、用途別市場規模（病院、専門クリニック、がん治療センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・軟骨肉腫治療の市場動向 ・企業の競争状況、市場シェア ・軟骨肉腫治療の種類別市場規模（外科的治療、化学療法、放射線療法） ・軟骨肉腫治療の用途別市場規模（病院、専門クリニック、がん治療センター） ・軟骨肉腫治療の北米市場規模2016-2027（アメリカ、カナダ） ・軟骨肉腫治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・軟骨肉腫治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・軟骨肉腫治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・軟骨肉腫治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Hoffmann-La Roche、AEterna Zentaris、Acorn Research、Agios Pharmaceuticals、Infinity Pharmaceuticals） ・結論 |
Chondrosarcoma refers to cancer of cartilage, a flexible connective tissue found in joints between bones, the ear, the rib cage etc. According to Cancer Network Journal, chondrosarcoma contributes to almost half of the osteosarcoma cases and is the second most common type of osteosacrcoma (tumor of bones). Chondrosarcoma can start at any age but most commonly found in adults above the age of 20 years. As per the statistics of American Cancer Society, occurrence of chondrosarcoma in patients younger than 20 years is less than 5%. Chondrosarcoma mainly affects the cartilage of arms, ribs, pelvis, and scapula and rarely found in trachea, breast and other parts of the body showing presence of cartilage tissue. Chondrosarcoma patients do not show any symptoms at an early stage hence, it can only be diagnosed in the late stage of a tumor when it shows fracture and bony bump at the tumor site. Diagnosis of chondrosarcoma can be done using radiography (X-Ray), computerized tomography (CT scan) or magnetic resonance imaging (MRI). Unlike other cancers chondrosarcoma is resistant to chemotherapy and radiation therapy and can primarily be treated with surgery. Surgical procedures for chondrosarcoma treatment involve limb sparing operations, complete surgical ablation and amputation in certain cases.
Increasing prevalence of osteosarcoma can ultimately influence the growth of global chondrosarcoma treatment market. According to Cancer Network Journal the incidence of osteosacrcoma in the U.S. is approximately 800 cases per year. Other factors responsible for growth of global chondrosarcoma treatment market include growing prevalence of genetic diseases.
Market Analysis and Insights: Global Chondrosarcoma Treatment Market
The global Chondrosarcoma Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Chondrosarcoma Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Chondrosarcoma Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Chondrosarcoma Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Chondrosarcoma Treatment market.
Global Chondrosarcoma Treatment Scope and Market Size
Chondrosarcoma Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Chondrosarcoma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Surgical Treatment
Chemotherapy
Radiation Therapy
Segment by Application
Hospitals
Multispecialty Clinics
Cancer Treatment Centers
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Hoffmann-La Roche
AEterna Zentaris
Acorn Research
Agios Pharmaceuticals
Infinity Pharmaceuticals
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chondrosarcoma Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Surgical Treatment
1.2.3 Chemotherapy
1.2.4 Radiation Therapy
1.3 Market by Application
1.3.1 Global Chondrosarcoma Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Multispecialty Clinics
1.3.4 Cancer Treatment Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Chondrosarcoma Treatment Market Perspective (2016-2027)
2.2 Chondrosarcoma Treatment Growth Trends by Regions
2.2.1 Chondrosarcoma Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Chondrosarcoma Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Chondrosarcoma Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Chondrosarcoma Treatment Industry Dynamic
2.3.1 Chondrosarcoma Treatment Market Trends
2.3.2 Chondrosarcoma Treatment Market Drivers
2.3.3 Chondrosarcoma Treatment Market Challenges
2.3.4 Chondrosarcoma Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chondrosarcoma Treatment Players by Revenue
3.1.1 Global Top Chondrosarcoma Treatment Players by Revenue (2016-2021)
3.1.2 Global Chondrosarcoma Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Chondrosarcoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Chondrosarcoma Treatment Revenue
3.4 Global Chondrosarcoma Treatment Market Concentration Ratio
3.4.1 Global Chondrosarcoma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chondrosarcoma Treatment Revenue in 2020
3.5 Chondrosarcoma Treatment Key Players Head office and Area Served
3.6 Key Players Chondrosarcoma Treatment Product Solution and Service
3.7 Date of Enter into Chondrosarcoma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chondrosarcoma Treatment Breakdown Data by Type
4.1 Global Chondrosarcoma Treatment Historic Market Size by Type (2016-2021)
4.2 Global Chondrosarcoma Treatment Forecasted Market Size by Type (2022-2027)
5 Chondrosarcoma Treatment Breakdown Data by Application
5.1 Global Chondrosarcoma Treatment Historic Market Size by Application (2016-2021)
5.2 Global Chondrosarcoma Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Chondrosarcoma Treatment Market Size (2016-2027)
6.2 North America Chondrosarcoma Treatment Market Size by Type
6.2.1 North America Chondrosarcoma Treatment Market Size by Type (2016-2021)
6.2.2 North America Chondrosarcoma Treatment Market Size by Type (2022-2027)
6.2.3 North America Chondrosarcoma Treatment Market Size by Type (2016-2027)
6.3 North America Chondrosarcoma Treatment Market Size by Application
6.3.1 North America Chondrosarcoma Treatment Market Size by Application (2016-2021)
6.3.2 North America Chondrosarcoma Treatment Market Size by Application (2022-2027)
6.3.3 North America Chondrosarcoma Treatment Market Size by Application (2016-2027)
6.4 North America Chondrosarcoma Treatment Market Size by Country
6.4.1 North America Chondrosarcoma Treatment Market Size by Country (2016-2021)
6.4.2 North America Chondrosarcoma Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Chondrosarcoma Treatment Market Size (2016-2027)
7.2 Europe Chondrosarcoma Treatment Market Size by Type
7.2.1 Europe Chondrosarcoma Treatment Market Size by Type (2016-2021)
7.2.2 Europe Chondrosarcoma Treatment Market Size by Type (2022-2027)
7.2.3 Europe Chondrosarcoma Treatment Market Size by Type (2016-2027)
7.3 Europe Chondrosarcoma Treatment Market Size by Application
7.3.1 Europe Chondrosarcoma Treatment Market Size by Application (2016-2021)
7.3.2 Europe Chondrosarcoma Treatment Market Size by Application (2022-2027)
7.3.3 Europe Chondrosarcoma Treatment Market Size by Application (2016-2027)
7.4 Europe Chondrosarcoma Treatment Market Size by Country
7.4.1 Europe Chondrosarcoma Treatment Market Size by Country (2016-2021)
7.4.2 Europe Chondrosarcoma Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Chondrosarcoma Treatment Market Size (2016-2027)
8.2 Asia-Pacific Chondrosarcoma Treatment Market Size by Type
8.2.1 Asia-Pacific Chondrosarcoma Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Chondrosarcoma Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Chondrosarcoma Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Chondrosarcoma Treatment Market Size by Application
8.3.1 Asia-Pacific Chondrosarcoma Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Chondrosarcoma Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Chondrosarcoma Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Chondrosarcoma Treatment Market Size by Region
8.4.1 Asia-Pacific Chondrosarcoma Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Chondrosarcoma Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Chondrosarcoma Treatment Market Size (2016-2027)
9.2 Latin America Chondrosarcoma Treatment Market Size by Type
9.2.1 Latin America Chondrosarcoma Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Chondrosarcoma Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Chondrosarcoma Treatment Market Size by Type (2016-2027)
9.3 Latin America Chondrosarcoma Treatment Market Size by Application
9.3.1 Latin America Chondrosarcoma Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Chondrosarcoma Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Chondrosarcoma Treatment Market Size by Application (2016-2027)
9.4 Latin America Chondrosarcoma Treatment Market Size by Country
9.4.1 Latin America Chondrosarcoma Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Chondrosarcoma Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chondrosarcoma Treatment Market Size (2016-2027)
10.2 Middle East & Africa Chondrosarcoma Treatment Market Size by Type
10.2.1 Middle East & Africa Chondrosarcoma Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Chondrosarcoma Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Chondrosarcoma Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Chondrosarcoma Treatment Market Size by Application
10.3.1 Middle East & Africa Chondrosarcoma Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Chondrosarcoma Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Chondrosarcoma Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Chondrosarcoma Treatment Market Size by Country
10.4.1 Middle East & Africa Chondrosarcoma Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Chondrosarcoma Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Hoffmann-La Roche
11.1.1 Hoffmann-La Roche Company Details
11.1.2 Hoffmann-La Roche Business Overview
11.1.3 Hoffmann-La Roche Chondrosarcoma Treatment Introduction
11.1.4 Hoffmann-La Roche Revenue in Chondrosarcoma Treatment Business (2016-2021)
11.1.5 Hoffmann-La Roche Recent Development
11.2 AEterna Zentaris
11.2.1 AEterna Zentaris Company Details
11.2.2 AEterna Zentaris Business Overview
11.2.3 AEterna Zentaris Chondrosarcoma Treatment Introduction
11.2.4 AEterna Zentaris Revenue in Chondrosarcoma Treatment Business (2016-2021)
11.2.5 AEterna Zentaris Recent Development
11.3 Acorn Research
11.3.1 Acorn Research Company Details
11.3.2 Acorn Research Business Overview
11.3.3 Acorn Research Chondrosarcoma Treatment Introduction
11.3.4 Acorn Research Revenue in Chondrosarcoma Treatment Business (2016-2021)
11.3.5 Acorn Research Recent Development
11.4 Agios Pharmaceuticals
11.4.1 Agios Pharmaceuticals Company Details
11.4.2 Agios Pharmaceuticals Business Overview
11.4.3 Agios Pharmaceuticals Chondrosarcoma Treatment Introduction
11.4.4 Agios Pharmaceuticals Revenue in Chondrosarcoma Treatment Business (2016-2021)
11.4.5 Agios Pharmaceuticals Recent Development
11.5 Infinity Pharmaceuticals
11.5.1 Infinity Pharmaceuticals Company Details
11.5.2 Infinity Pharmaceuticals Business Overview
11.5.3 Infinity Pharmaceuticals Chondrosarcoma Treatment Introduction
11.5.4 Infinity Pharmaceuticals Revenue in Chondrosarcoma Treatment Business (2016-2021)
11.5.5 Infinity Pharmaceuticals Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Chondrosarcoma Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Surgical Treatment
Table 3. Key Players of Chemotherapy
Table 4. Key Players of Radiation Therapy
Table 5. Global Chondrosarcoma Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Chondrosarcoma Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Chondrosarcoma Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Chondrosarcoma Treatment Market Share by Regions (2016-2021)
Table 9. Global Chondrosarcoma Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Chondrosarcoma Treatment Market Share by Regions (2022-2027)
Table 11. Chondrosarcoma Treatment Market Trends
Table 12. Chondrosarcoma Treatment Market Drivers
Table 13. Chondrosarcoma Treatment Market Challenges
Table 14. Chondrosarcoma Treatment Market Restraints
Table 15. Global Chondrosarcoma Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Chondrosarcoma Treatment Market Share by Players (2016-2021)
Table 17. Global Top Chondrosarcoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chondrosarcoma Treatment as of 2020)
Table 18. Ranking of Global Top Chondrosarcoma Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Chondrosarcoma Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Chondrosarcoma Treatment Product Solution and Service
Table 22. Date of Enter into Chondrosarcoma Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Chondrosarcoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Chondrosarcoma Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Chondrosarcoma Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Chondrosarcoma Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Chondrosarcoma Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Chondrosarcoma Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Chondrosarcoma Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Chondrosarcoma Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Chondrosarcoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Chondrosarcoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Chondrosarcoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Chondrosarcoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Chondrosarcoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Chondrosarcoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Chondrosarcoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Chondrosarcoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Chondrosarcoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Chondrosarcoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Chondrosarcoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Chondrosarcoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Chondrosarcoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Chondrosarcoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Chondrosarcoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Chondrosarcoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Chondrosarcoma Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Chondrosarcoma Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Chondrosarcoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Chondrosarcoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Chondrosarcoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Chondrosarcoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Chondrosarcoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Chondrosarcoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Chondrosarcoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Chondrosarcoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Chondrosarcoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Chondrosarcoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Chondrosarcoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Chondrosarcoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Hoffmann-La Roche Company Details
Table 63. Hoffmann-La Roche Business Overview
Table 64. Hoffmann-La Roche Chondrosarcoma Treatment Product
Table 65. Hoffmann-La Roche Revenue in Chondrosarcoma Treatment Business (2016-2021) & (US$ Million)
Table 66. Hoffmann-La Roche Recent Development
Table 67. AEterna Zentaris Company Details
Table 68. AEterna Zentaris Business Overview
Table 69. AEterna Zentaris Chondrosarcoma Treatment Product
Table 70. AEterna Zentaris Revenue in Chondrosarcoma Treatment Business (2016-2021) & (US$ Million)
Table 71. AEterna Zentaris Recent Development
Table 72. Acorn Research Company Details
Table 73. Acorn Research Business Overview
Table 74. Acorn Research Chondrosarcoma Treatment Product
Table 75. Acorn Research Revenue in Chondrosarcoma Treatment Business (2016-2021) & (US$ Million)
Table 76. Acorn Research Recent Development
Table 77. Agios Pharmaceuticals Company Details
Table 78. Agios Pharmaceuticals Business Overview
Table 79. Agios Pharmaceuticals Chondrosarcoma Treatment Product
Table 80. Agios Pharmaceuticals Revenue in Chondrosarcoma Treatment Business (2016-2021) & (US$ Million)
Table 81. Agios Pharmaceuticals Recent Development
Table 82. Infinity Pharmaceuticals Company Details
Table 83. Infinity Pharmaceuticals Business Overview
Table 84. Infinity Pharmaceuticals Chondrosarcoma Treatment Product
Table 85. Infinity Pharmaceuticals Revenue in Chondrosarcoma Treatment Business (2016-2021) & (US$ Million)
Table 86. Infinity Pharmaceuticals Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chondrosarcoma Treatment Market Share by Type: 2020 VS 2027
Figure 2. Surgical Treatment Features
Figure 3. Chemotherapy Features
Figure 4. Radiation Therapy Features
Figure 5. Global Chondrosarcoma Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Multispecialty Clinics Case Studies
Figure 8. Cancer Treatment Centers Case Studies
Figure 9. Chondrosarcoma Treatment Report Years Considered
Figure 10. Global Chondrosarcoma Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Chondrosarcoma Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Chondrosarcoma Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Chondrosarcoma Treatment Market Share by Regions (2022-2027)
Figure 14. Global Chondrosarcoma Treatment Market Share by Players in 2020
Figure 15. Global Top Chondrosarcoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chondrosarcoma Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Chondrosarcoma Treatment Revenue in 2020
Figure 17. Global Chondrosarcoma Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Chondrosarcoma Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Chondrosarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Chondrosarcoma Treatment Market Share by Type (2016-2027)
Figure 21. North America Chondrosarcoma Treatment Market Share by Application (2016-2027)
Figure 22. North America Chondrosarcoma Treatment Market Share by Country (2016-2027)
Figure 23. United States Chondrosarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Chondrosarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Chondrosarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Chondrosarcoma Treatment Market Share by Type (2016-2027)
Figure 27. Europe Chondrosarcoma Treatment Market Share by Application (2016-2027)
Figure 28. Europe Chondrosarcoma Treatment Market Share by Country (2016-2027)
Figure 29. Germany Chondrosarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Chondrosarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Chondrosarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Chondrosarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Chondrosarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Chondrosarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Chondrosarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Chondrosarcoma Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Chondrosarcoma Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Chondrosarcoma Treatment Market Share by Region (2016-2027)
Figure 39. China Chondrosarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Chondrosarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Chondrosarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Chondrosarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Chondrosarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Chondrosarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Chondrosarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Chondrosarcoma Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Chondrosarcoma Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Chondrosarcoma Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Chondrosarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Chondrosarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Chondrosarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Chondrosarcoma Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Chondrosarcoma Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Chondrosarcoma Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Chondrosarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Chondrosarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Chondrosarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Hoffmann-La Roche Revenue Growth Rate in Chondrosarcoma Treatment Business (2016-2021)
Figure 59. AEterna Zentaris Revenue Growth Rate in Chondrosarcoma Treatment Business (2016-2021)
Figure 60. Acorn Research Revenue Growth Rate in Chondrosarcoma Treatment Business (2016-2021)
Figure 61. Agios Pharmaceuticals Revenue Growth Rate in Chondrosarcoma Treatment Business (2016-2021)
Figure 62. Infinity Pharmaceuticals Revenue Growth Rate in Chondrosarcoma Treatment Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
世界の陰茎がん治療市場規模・現状・予測（2021年-2027年） Therapy of penile cancer. Market Analysis and Insights: Global Penile Cancer Treatment Market The global Penile Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and h…- 世界の転移性がん治療市場規模・現状・予測（2021年-2027年） Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body. Some of the most common organs which are affected by metastatic breast cancer are brain, liver, bones and lungs. It is also known as stage IV breast can…
- 世界の非血液がん治療市場規模・現状・予測（2021年-2027年） Non-Hematological cancers which cover lung cancer, prostate cancer, breast cancer and others, this type of cancer are not show easily diagnosis and the treatment process is also show long that some time it lead to the death of the patient. North America has the huge number of population suffering fr…
- 世界の非血液がん治療市場規模・現状・予測（2021年-2027年） Non-Hematological cancers which cover lung cancer, prostate cancer, breast cancer and others, this type of cancer are not show easily diagnosis and the treatment process is also show long that some time it lead to the death of the patient. North America has the huge number of population suffering fr…
- 世界の乳がん治療市場規模・現状・予測（2021年-2027年） Breast cancer is the one of the most prevalent cancer and among the leading cause of death in cancer patients. According, to WHO 2013 report 50800 women died of breast cancer in 2011. Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread …